I

iBio
D

IBIO

0.73160
USD
-0.01
(-1.63%)
مغلق
حجم التداول
118
الربح لكل سهم
-2
العائد الربحي
-
P/E
-18
حجم السوق
11,866,026
أصول ذات صلة
A
ALT
-0.02500
(-0.61%)
4.07500 USD
A
AMRN
-0.070
(-0.45%)
15.450 USD
A
AXSM
-4.200
(-4.00%)
100.830 USD
E
EVOK
0.03000
(0.67%)
4.48000 USD
I
INO
-0.03500
(-2.33%)
1.47000 USD
T
TTNP
-0.81000
(-15.52%)
4.41000 USD
V
VSTM
0.84500
(15.96%)
6.14000 USD
X
XENE
-0.710
(-2.29%)
30.300 USD
المزيد
الأخبار المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.